CME Program Detail

Title: Opportunities and Challenges to Address the Opioid Epidemic
Date: Tue, Sep 17th, 2019
Time: 7:30 am - 1:00 pm
Location: Lang Auditorium

Statement of Need:
Purpose of the program is to educate on how opiates work, learn alternative pain management techniques, and gain knowledge on treating acute opiate overdose and chronic addiction

Target Audience:
Physicians, Pharmacists, Podiatrists, Physician Assistants, Pharmacist, Pharmacy Assistants, Nurses, Nurse Practitioners, others clinicians involved in the care of patients with chronic pain.


Ketan Patel, Ph.D.
Vijaya Korlipara, Ph.D.
Hira Shafeeq, Pharm.D.
Samantha Jellinek-Cohen, Pharm.D.
Joanne Carroll, Ph.D.
Maha Saad, Pharm.D.
Farah Khorassani, Pharm.D.
Sarah Smith, Pharm.D.
Olga Hilas, Pharm.D.

Disclosures: None


Joseph Cooke, M.D. and William Malone


1. Explain the basic mechanism of action of opioid medications.
2. Describe novel strategies for the development of safe and effective pain medications.
3. Review current opioids for pain management.
4. Describe optimal prescribing for acute and chronic pain management with opioids.
5. Identify evidence-based non-opioid options for treatment of pain.
6. Consider alternatives to opioid medications for treatment of various pain syndromes.
7. Describe the current scope of the problem in the U.S.
8. Describe the demographics of opioid use and misuse in the U.S.
9. Identify determinants contributing to the current opioid epidemic in the U.S.
10. Review clinical cases for acute and chronic pain management.
11. Formulate safe and effective care plans for pain management.
12. Identify risk factors and key features of opioid use disorder (OUD).
13. Review best practices for integrated medication-assisted treatment (MAT).
14. Discuss current legislation/policy that impacts professional prescribing, dispensing and administration of opioid medications.
15. Discuss public health strategies to combat the opioid crisis.
16. Explore challenges and solutions for health care providers/professionals in addressing opioid misuse.
17. Identify risk factors and signs of an opioid overdose.
18. Describe the appropriate use of naloxone for an opioid overdose.


7:30am – 8:15am

8:15am – 8:30am
Welcome Remarks

8:30am – 9:30am
Pharmacology and Medicinal Chemistry of Opioid Medications
Ketan Patel, Ph.D. & Vijaya Korlipara, Ph.D.

Therapeutic Considerations in the Prescribing of Opioids
Hira Shafeeq, Pharm.D.

9:30am – 10:30am
Multi-modal (non-opioid) Approaches to Pain Management
Samantha Jellinek-Cohen, Pharm.D.

Epidemiology of Opioid Misuse and Addiction
Joanne Carroll, Ph.D.

10:30am - 10:45am

10:45am – 11:45am
Therapeutic Cases
Maha Saad, Pharm.D.

Identification and Treatment of Opioid Use Disorder
Farah Khorassani, Pharm.D.

11:45am – 12:00pm

12:00pm – 1:00pm
Regulatory Policy and Harm Reduction Strategies
Sarah Smith, Pharm.D.

Opioid Overdose Prevention and Response
Olga Hilas, Pharm.D.

NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

NewYork Presbyterian/Queens designates this Live Activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Approval for Podiatric Medical Education

NewYork Presbyterian/Queens is approved by the Council on Podiatric Medical Education as a provider of continuing medical education in podiatric medicine. NewYork Presbyterian/Queens has approved this activity for a maximum of 4.0 continuing education contact hours.

Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.

<< Back to Programs List

<< Back to Program Archive